William Blair


William Blair’s Take on EndoChoice Holdings Inc (GI) Amid Acquisition by Boston Scientific

Yesterday, EndoChoice Holdings Inc (NYSE:GI) that it entered a definitive agreement to be acquired by Boston Scientific for $8 per share, a total …

William Blair Weighs in on Sarepta Therapeutics Inc (SRPT) Following Favorable Decision in Patent Appeal

Sarepta Therapeutics Inc (NASDAQ:SRPT) announced yesterday that the Patent Trial and Appeal Board issued two favorable decisions for Sarepta over an intellectual property and …

William Blair Upgrades and Bumps Up Price Target on Sarepta Therapeutics Inc (SRPT) Following FDA Accelerated Approval

On Monday, September 19th, the FDA granted accelerated approval to Sarepta Therapeutics Inc (NASDAQ:SRPT) pipeline drug eteplirsen (Exondys 51), designed to treat exon …

William Blair Dives in on Exelixis, Inc. (EXEL) Ahead of Phase II CABOSUN Data

William Blair analyst John Sonnier is out with a research report on Exelixis, Inc. (NASDAQ:EXEL) as the biotech company’s shares have been shooting …

William Blair Cautious on Cummins Inc. (CMI) Amid Navistar Volkswagen Deal

William Blair analyst Lawrence De Maria provides commentary on Cummins Inc. (NYSE:CMI) on the heels of Navistar announcing a deal where Volkswagen will …

William Blair Remains Positive on Dynavax Technologies Corporation (DVAX) Despite FDA VRBPAC Meeting Cancellation

Dynavax Technologies Corporation (NASDAQ:DVAX) shares have tumbled recently on the heels of last Friday’s FDA announcement of the cancellation of the November 16, 2016 …

William Blair Reiterates Upbeat View on General Electric Company (GE) Following Two Additive Manufacturing Acquisitions

General Electric Company (NYSE:GE) announced an agreement to acquire two small European metal additive manufacturers for a collective, hefty price tag of $1.4 …

William Blair Chimes in on Ciena Corporation (CIEN) Following F3Q:16 Results

Ciena Corporation (NYSE:CIEN) posted results for its fiscal third-quarter performance yesterday that has left William Blair analyst Dmitry Netis finding “many positives to …

Here’s Why William Blair Upgraded Netflix, Inc. (NFLX)

We believe the long-term risk/reward is favorable for Netflix, says William Blair

William Blair Weighs In On Under Armour Inc (UA) Following Management Meetings

We like shares given continued healthy sales trends, says William Blair

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts